0001593968-24-000842.txt : 20240611 0001593968-24-000842.hdr.sgml : 20240611 20240611161019 ACCESSION NUMBER: 0001593968-24-000842 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240605 FILED AS OF DATE: 20240611 DATE AS OF CHANGE: 20240611 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Yoshiyama Annie CENTRAL INDEX KEY: 0001835208 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38693 FILM NUMBER: 241035853 MAIL ADDRESS: STREET 1: 7000 SHORELINE COURT STREET 2: SUITE 201 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Allogene Therapeutics, Inc. CENTRAL INDEX KEY: 0001737287 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 823562771 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 210 EAST GRAND AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: (650) 457-2700 MAIL ADDRESS: STREET 1: 210 EAST GRAND AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 3 1 primary_01.xml PRIMARY DOCUMENT X0206 3 2024-06-05 0 0001737287 Allogene Therapeutics, Inc. ALLO 0001835208 Yoshiyama Annie 210 EAST GRAND AVE SOUTH SAN FRANCISCO 94080 true SVP, Finance Common Stock 101758 D Stock Option (Right to buy) 3.98 2034-04-08 Common Stock 348708 D Constitutes restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting, 1/4th of the RSUs will vest on April 20th, 2025 and the remainder will vest annually thereafter. 25% of the shares subject to the stock option shall vest on April 8, 2025, and the remaining shares shall vest in 36 equal monthly installments thereafter. /s/Annie Yoshiyama 2024-06-11